Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,632,424
+$337,388 QoQ
Shares Held
1,361
-3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#2,688
of 4,605 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EXCALIBUR MANAGEMENT CORP holds $32,863,371 across 10 Drug Manufacturers - General names. LLY ranks #8 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,287 | $9,469,779 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,387 | $6,731,729 | |
| 3 | PFE |
Pfizer Inc
|
155,777 | $3,751,110 | |
| 4 | ABBV |
AbbVie Inc.
|
13,505 | $3,398,398 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,349 | $2,697,232 | |
| 6 | AMGN |
Amgen Inc
|
6,407 | $2,320,102 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,161 | $1,968,356 | |
| 8 | LLY |
ELI LILLY & Co
This page
|
1,361 | $1,632,424 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,632,424 | 1,361 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,295,036 | 1,408 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,442,220 | 1,342 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,065,911 | 1,397 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,105,373 | 1,418 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,212,435 | 1,468 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,131,752 | 1,466 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,220,825 | 1,378 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,242,181 | 1,372 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,002,790 | 1,289 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $751,383 | 1,289 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $692,360 | 1,289 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $596,073 | 1,271 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $433,396 | 1,262 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $461,690 | 1,262 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $408,067 | 1,262 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $409,178 | 1,262 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $361,112 | 1,261 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $348,313 | 1,261 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $291,354 | 1,261 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $289,424 | 1,261 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $233,525 | 1,250 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $211,050 | 1,250 | Shares | Sole | 2021-01-26 | |
| 2020-06-30 | $205,225 | 1,250 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||